Joshua Fink is the Founder and Managing Partner of Luma Group – an investment management firm focused on biotech, medical device companies, and other technologies designed to improve human health and reduce pharmaceutical drug development costs. Over a 20+ year career, the last 8 focused exclusively in healthcare, Josh has helped create and unlock substantial shareholder value across dozens of public and private companies around the world and built a deep network of executives, entrepreneurs, investors, and strategists positioned at the leading edge of healthcare innovation and science. Josh is actively involved in the World Economic Forum and has been dedicated to a number of philanthropic initiatives that include supporting medical institutions and foundations, educational initiatives, and access to healthcare. Josh’s nonprofit work also includes serving on the Board of Directors of Panthera, which is dedicated to ensuring a future for the wild cats of the world. He is also a member of the Fund for the Twenty-First Century and the Committee of Drawings and Prints at the Museum of Modern Art. He is a graduate of the University of Pennsylvania.